✦ LIBER ✦

Level-I evidence for prognostic impact of UPA and PAI-1 in node-negative breast cancer patients: Ready for use in clinical routine

✍ Scribed by C. Thomssen; N. Harbeck; C. Meisner; A. Prechtl; M. Untch; B. Lisboa; H. Selbmann; M. Schmitt; F. Jaenicke

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

648 Prognostic significance of UPA and P

✍ A.S. Knoop; A.V. Lœnkholm; S. Hansen; J. Andersen; P.A. Andreasen; J.A. Andersen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 134 KB

The prognostic impact of Plasminogen Act

✍ A. Artmann; K. Celik; M. Kiechle; M. Schmitt; N. Harbeck 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Urokinase-type plasminogen activator (uP

✍ C. Thomssen; M. Vetter; D. Paepke; M. Schmidt; C. Veyret; D. Augustin; V. Hanf; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Ten-year analysis of the prospective mul

✍ Harbeck, N.; Schmitt, M.; Meisner, C.; Friedel, C.; Untch, M.; Schmidt, M.; Swee 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 715 KB

Routine clinical use of the one-step nuc

✍ Yasuhiro Tamaki; Nobuaki Sato; Keiichi Homma; Daisuke Takabatake; Rieko Nishimur 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

398 HLA-E and HLA-G tumour expression is

✍ E.M. De Kruijf; A. Sajet; J.G.H. van Nes; R. Natanov; H. Putter; V.T.H.B.M. Smit 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB